Israel VK - Search Results

1

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.

Kelly K, Crowley J, Bunn PA Jr, Presant CA, Grevstad PK, Moinpour CM, Ramsey SD, Wozniak AJ, Weiss GR, Moore DF, Israel VK, Livingston RB, Gandara DR. Kelly K, et al. Among authors: israel vk. J Clin Oncol. 2001 Jul 1;19(13):3210-8. doi: 10.1200/JCO.2001.19.13.3210. J Clin Oncol. 2001. PMID: 11432888 Clinical Trial.

2

Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.

Hesketh PJ, Chansky K, Israel V, Grapski RT, Mekhail TM, Spiridonidis CH, Mills GM, Kelly K, Crowley JJ, Gandara DR. Hesketh PJ, et al. J Thorac Oncol. 2007 May;2(5):440-4. doi: 10.1097/01.JTO.0000268678.25615.33. J Thorac Oncol. 2007. PMID: 17473660 Free article. Clinical Trial.

3

Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial.

Lau D, Leigh B, Gandara D, Edelman M, Morgan R, Israel V, Lara P, Wilder R, Ryu J, Doroshow J. Lau D, et al. J Clin Oncol. 2001 Jan 15;19(2):442-7. doi: 10.1200/JCO.2001.19.2.442. J Clin Oncol. 2001. PMID: 11208837 Clinical Trial.

4

Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer.

Edelman MJ, Gandara DR, Hausner P, Israel V, Thornton D, DeSanto J, Doyle LA. Edelman MJ, et al. Lung Cancer. 2003 Feb;39(2):197-9. doi: 10.1016/s0169-5002(02)00511-1. Lung Cancer. 2003. PMID: 12581573 Clinical Trial.

5

Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial.

Lara PN Jr, Gandara DR, Longmate J, Gumerlock PH, Lau DH, Edelman MJ, Gandour-Edwards R, Mack PC, Israel V, Raschko J, Frankel P, Perez EA, Lenz HJ, Doroshow JH. Lara PN Jr, et al. Cancer Chemother Pharmacol. 2001 Jul;48(1):22-8. doi: 10.1007/s002800100293. Cancer Chemother Pharmacol. 2001. PMID: 11488520 Clinical Trial.

6

Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer.

Socinski MA, Sandler AB, Miller LL, Locker PK, Hanover CK, Elfring GL, Israel VK, Pirotta N, Natale RB. Socinski MA, et al. Among authors: israel vk. J Clin Oncol. 2001 Feb 15;19(4):1078-87. doi: 10.1200/JCO.2001.19.4.1078. J Clin Oncol. 2001. PMID: 11181672 Clinical Trial.

7

Gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II California cancer consortium trial.

Lara PN Jr, Gumerlock PH, Mack PC, Lau DH, Gandour-Edwards R, Edelman MJ, Albain KS, Law LY, Longmate J, Frankel P, Reddy GP, Israel V, Doroshow JH, Gandara DR. Lara PN Jr, et al. Clin Lung Cancer. 2004 Sep;6(2):102-7. doi: 10.3816/CLC.2004.n.023. Clin Lung Cancer. 2004. PMID: 15476595 Clinical Trial.

8

Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation.

Weitz IC, Israel VK, Waisman JR, Presant CA, Rochanda L, Liebman HA. Weitz IC, et al. Among authors: israel vk. Thromb Haemost. 2002 Aug;88(2):213-20. Thromb Haemost. 2002. PMID: 12195692 Clinical Trial.

9

Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma.

Socinski MA, Sandler AB, Israel VK, Gillenwater HH, Miller LL, Locker PK, Antonellini A, Elfring GL, Natale RB. Socinski MA, et al. Among authors: israel vk. Cancer. 2002 Oct 1;95(7):1520-7. doi: 10.1002/cncr.10852. Cancer. 2002. PMID: 12237921 Free article. Clinical Trial.

10

Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC).

Israel V, Tagawa ST, Snyder T, Jeffers S, Raghavan D. Israel V, et al. Invest New Drugs. 2004 Aug;22(3):291-7. doi: 10.1023/B:DRUG.0000026255.34988.96. Invest New Drugs. 2004. PMID: 15122076 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page